Accuray strikes deal with Siemens:
This article was originally published in Clinica
Radiosurgery systems developer Accuray is to combine its robotic radiosurgery technology with Siemens Medical Solutions' diagnostic imaging know-how, following a distribution and co-marketing deal between the two companies. Under the terms of the agreement, Accuray's CyberKnife robotic radiosurgery system and RoboCouch patient positioning system will be integrated into Siemen's Somatom computed tomography scanner with a sliding gantry configuration. Shares in Sunnyvale, California-based Accuray rose $0.42 (2%) to close at $23.78 on April 12, the day after the announcement.
You may also be interested in...
Officials from the US Food and Drug Administration cited their reasons for refusing to review new applications for companies with unresolved data integrity failures.
However, Vaccinex sees possible efficacy for SEMA4D inhibition in later-stage Huntington’s as well as Alzheimer’s disease. Pepinemab is also being studied with Keytruda in head-and-neck cancer.
In last year’s acquisition, Bristol Myers Squibb agreed to pay Celgene investors another $9 per share based on three approvals, including idecabtagene vicleucel (bb2121) by 30 March 2021.